LENZ
LENZ Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
LENZ Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
No other changes.
No other changes.
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of LENZ Therapeutics, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Amgen Inc, Gilead Sciences, Inc., Biogen Inc. and 3 more; of LENZ Therapeutics, Inc.'s 6 closest co-movers, none share that code.
LENZ Therapeutics, Inc.
3.52
+0.02 · +0.45%
post 3.46 −1.57%
| Manager | Value | % base | |
|---|---|---|---|
| RA Capital Management | $23.7M | 11.92% | 0.00% |
| Falcon Edge Capital | $20.5M | 10.30% | 0.00% |
| FMR | $20.2M | 10.15% | −1.08% |
| Versant Venture | $15.1M | 7.58% | 0.00% |
| BlackRockindex-like | $13.0M | 6.54% | +15.95% |
| Manager | Value | % base | |
|---|---|---|---|
| RA Capital Management | $23.7M | 11.92% | 0.00% |
| Falcon Edge Capital | $20.5M | 10.30% | 0.00% |
| FMR | $20.2M | 10.15% | −1.08% |
| Versant Venture | $15.1M | 7.58% | 0.00% |
| BlackRockindex-like | $13.0M | 6.54% | +15.95% |
Bull3
Bear1
Expected move
Inputsspot 3.46exp Jan 15ATM strike 2.5ATM straddle 1.25IV 67%